Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
54 | 4646 | 41.3 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
876 | 10798 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//ABCG2 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | P GLYCOPROTEIN | Author keyword | 277 | 22% | 24% | 1133 |
2 | MULTIDRUG RESISTANCE | Author keyword | 240 | 20% | 23% | 1081 |
3 | PSC 833 | Author keyword | 31 | 57% | 1% | 37 |
4 | S9788 | Author keyword | 21 | 85% | 0% | 11 |
5 | MDR | Author keyword | 19 | 15% | 3% | 117 |
6 | MULTIDRUG RESISTANCE MDR | Author keyword | 18 | 26% | 1% | 58 |
7 | MDR MODULATORS | Author keyword | 17 | 68% | 0% | 15 |
8 | SDZ PSC 833 | Author keyword | 16 | 58% | 0% | 19 |
9 | DEXNIGULDIPINE HCL | Author keyword | 15 | 88% | 0% | 7 |
10 | MS 209 | Author keyword | 15 | 73% | 0% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | P GLYCOPROTEIN | 277 | 22% | 24% | 1133 | Search P+GLYCOPROTEIN | Search P+GLYCOPROTEIN |
2 | MULTIDRUG RESISTANCE | 240 | 20% | 23% | 1081 | Search MULTIDRUG+RESISTANCE | Search MULTIDRUG+RESISTANCE |
3 | PSC 833 | 31 | 57% | 1% | 37 | Search PSC+833 | Search PSC+833 |
4 | S9788 | 21 | 85% | 0% | 11 | Search S9788 | Search S9788 |
5 | MDR | 19 | 15% | 3% | 117 | Search MDR | Search MDR |
6 | MULTIDRUG RESISTANCE MDR | 18 | 26% | 1% | 58 | Search MULTIDRUG+RESISTANCE+MDR | Search MULTIDRUG+RESISTANCE+MDR |
7 | MDR MODULATORS | 17 | 68% | 0% | 15 | Search MDR+MODULATORS | Search MDR+MODULATORS |
8 | SDZ PSC 833 | 16 | 58% | 0% | 19 | Search SDZ+PSC+833 | Search SDZ+PSC+833 |
9 | DEXNIGULDIPINE HCL | 15 | 88% | 0% | 7 | Search DEXNIGULDIPINE+HCL | Search DEXNIGULDIPINE+HCL |
10 | MS 209 | 15 | 73% | 0% | 11 | Search MS+209 | Search MS+209 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BACTERIAL TRANSPORT PROTEINS | 217 | 65% | 4% | 208 |
2 | MULTIDRUG RESISTANCE GENE | 115 | 27% | 8% | 364 |
3 | SDZ PSC 833 | 105 | 63% | 2% | 105 |
4 | VINCRISTINE RESISTANCE | 99 | 66% | 2% | 91 |
5 | P388 LEUKEMIA | 80 | 60% | 2% | 87 |
6 | DOXORUBICIN RESISTANCE | 80 | 52% | 2% | 107 |
7 | HIGH DOSE VERAPAMIL | 79 | 94% | 1% | 29 |
8 | MULTIDRUG RESISTANT CELLS | 72 | 46% | 3% | 117 |
9 | STIMULATED ATPASE ACTIVITY | 59 | 61% | 1% | 63 |
10 | P GLYCOPROTEIN EXPRESSION | 58 | 19% | 6% | 282 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SELECTIVE CANCER THERAPEUTICS | 1 | 13% | 0% | 8 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER | 1993 | 3128 | 224 | 79% |
Biochemical, cellular, and pharmacological aspects of the multidrug transporter | 1999 | 1272 | 159 | 87% |
Multidrug resistance in cancer: Role of ATP-dependent transporters | 2002 | 2222 | 155 | 31% |
Targeting multidrug resistance in cancer | 2006 | 1240 | 239 | 25% |
From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance | 2001 | 468 | 212 | 57% |
P-glycoprotein - A mediator of multidrug resistance in tumour cells | 1996 | 373 | 252 | 87% |
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE | 1989 | 1998 | 175 | 82% |
Multidrug resistance (MDR) in cancer - Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs | 2000 | 531 | 221 | 51% |
ABC multidrug transporters: structure, function and role in chemoresistance | 2008 | 320 | 182 | 34% |
Genetic analysis of the multidrug transporter | 1995 | 351 | 220 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | QUIM MED CEQUIMED UP | 8 | 100% | 0.1% | 5 |
2 | GRP MEMBRANE BIOL | 8 | 36% | 0.4% | 17 |
3 | CANADIAN HLTH GRP MEMBRANE BIOL | 7 | 57% | 0.2% | 8 |
4 | UROLUROONCOL | 4 | 75% | 0.1% | 3 |
5 | PHYSICOCHIM BIOMOL CELLULAIRE | 4 | 18% | 0.4% | 20 |
6 | GUELPH WATERLOO CHEM BIOCHEM | 3 | 60% | 0.1% | 3 |
7 | UP A 7033 | 3 | 42% | 0.1% | 5 |
8 | IFR2 | 2 | 44% | 0.1% | 4 |
9 | CELLULAR BIOCHEMSAKYO KU | 2 | 67% | 0.0% | 2 |
10 | IMUNOL TUMORAL CIENCIAS SAUDE | 2 | 67% | 0.0% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228493 | MAJOR VAULT PROTEIN//LUNG RESISTANCE RELATED PROTEIN//VPARP |
2 | 0.0000214098 | L1210 CELL LINE//TCRP1//MOL PHYSIOL GENET |
3 | 0.0000177596 | MULTIXENOBIOTIC RESISTANCE//MOL ECOTOXICOL//MXR |
4 | 0.0000128847 | MRP1//MULTIDRUG RESISTANCE ASSOCIATED PROTEIN//DUBIN JOHNSON SYNDROME |
5 | 0.0000114235 | RHEUMATOLOTA KU//MDR I//DANINI HOSP |
6 | 0.0000111178 | P GLYCOPROTEIN//C3435T POLYMORPHISM//ABCB1 |
7 | 0.0000099901 | ABCG2//BCRP//BREAST CANCER RESISTANCE PROTEIN |
8 | 0.0000094815 | CEPHARANTHINE//STEPHANIA ROTUNDA//CEPHARANTHIN |
9 | 0.0000081738 | PHARMACOEPIGENETICS//ALFRED MED EDUC PROJECT//BANDUNG HOSP |
10 | 0.0000075902 | METHOXYMORPHOLINO DOXORUBICIN//AD 198//METHOXYMORPHOLINYL DOXORUBICIN |